Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells

Clinical and Experimental Immunology

Volumn 178, Issue 1, 2014, Pages 79-85

  Hodge, G ^a,c   Barnawi, J ^a,e   Jurisevic, C ^b   Moffat, D ^d   Holmes, M ^a,c   Reynolds, P N ^a,c   Jersmann, H ^a,c   Hodge, S ^a,c  

^a HANSON INSTITUTE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d Department of Surgical Pathology SA Pathology ^*  (Australia)

^e UNIVERSITY OF TABUK   (Saudi Arabia)

Author keywords

Cytotoxicity; Granzyme B; Interferon gamma; Lung cancer; NK and NK T like cells

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INDOMETACIN; PERFORIN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; GRANZYME;

ADULT; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER STAGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE EVASION; LUNG CANCER; LUNG CANCER CELL LINE; LUNG PARENCHYMA; LUNG RESECTION; MALE; MEDIATOR; NATURAL KILLER CELL; NATURAL KILLER T CELL; PATIENT IDENTIFICATION; PERSONAL EXPERIENCE; RETROSPECTIVE STUDY; T LYMPHOCYTE; BIOSYNTHESIS; IMMUNOLOGY; LUNG; LUNG TUMOR; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DINOPROSTONE; FEMALE; GRANZYMES; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PERFORIN; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908181343     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12392     Document Type: Article

References (17)

1. Fong K, Sekido Y, Gazdar A, Minna J. Lung cancer. 9: molecular biology of lung cancer: clinical implications. Thorax 2003; 58:892-900.
2. Tockman M, Anthonisen NR, Wright EC, Donithang G. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987; 106:512-18.
3. Skillrud D. COPD: causes, treatment, and risk for lung cancer. Compr Ther 1986; 12:13-6.
4. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359:1367-80.
5. Dehle FC, Mukaro VR, Jurisevic C et al. Defective efferocytosis in patients with lung cancer with or without COPD - mediated by PGE2 produced by lung cancer cells? PLOS ONE 2013; 8:e61573. Available at: http://dx.plos.org/10.1371/journal.pone.0061573 (accessed 26 April 2013).
6. Barrack ER. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 1997; 31:61-70.
7. Burkhardt BR, Lyle R, Qian K, Arnold AS, Cheng H, Atkinson MA, Zhang YC. Efficient delivery of siRNA into cytokinestimulated insulinoma cells silences Fas expression and inhibits Fas-mediated apoptosis. FEBS Lett 2006; 580:553-60.
8. Hodge G, Mukaro V, Holmes M, Reynolds PN, Hodge S. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway. Respirology 2013; 18:369-76.
9. Soriano C, Mukaro V, Hodge G et al. Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer:mechanism for immune evasion? Lung Cancer 2012; 77:38-45.
10. Travis WD, Brambilla E,Muller-Hermelink HK, Harris CC.World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon:IARC Press, 2004.
11. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (2011). Available at: http://www.goldcopd.org/(accessed 28 January 2012).
12. Hodge G, Hodge S, Li-Liew C, Reynolds PN, Holmes M. Increased natural killer T-like cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant recipients. Respirology 2012; 17:155-63.
13. Hodge S, Hodge G, Nairn J, Holmes M, Reynolds PN. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD 2006; 3:1-9.
14. Hodge G, Reynolds PN, Holmes M, Hodge S. Differential expression of pro-inflammatory cytokines in intra-epithelial T cells between trachea and bronchi distinguishes severity of COPD. Cytokine 2012; 60:843-8.
15. Hou R, Goloubeva O, Neuberg DS, Strominger JL, Wilson SB. Interleukin-12 and interleukin-2-induced invariant natural killer T-cell cytokine secretion and perforin expression independent of T-cell receptor activation. Immunology 2003; 110:30-7.
16. Orange JS, Chehimi J, Ghavimi D, Campbell D, Sullivan KE. Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b. Clin Immunol 2001; 99:53-64.
17. Wang H, Yang D, Xu W et al. Tumor-derived soluble MICs impair CD3(+)CD56(+) NKT-like cell cytotoxicity in cancer patients. Immunol Lett 2008; 120:65-71.